After a series of offers, Takeda (TYO:4502) said today that it reached an agreement with Shire (NSDQ:SHPG) to acquire the U.S.-based company in a deal valued at $62 billion.
The merger was approved by both companies’ boards of directors, according to Takeda, and is slated to close in the first half of 2019. Takeda investors are wary of the enormous pricetag – shares are down -20% since the Japanese company first announced its interest in buying Shire last month.
Get the full story at our sister site, Drug Delivery Business News.
The post Takeda reaches $62B deal to buy Shire appeared first on MassDevice.